NCT05709015

Brief Summary

Electrolysed water (EOW) is produced by the electrolysis of sodium chloride in an aqueous solution, producing chlorine gas at the anode and sodium hydroxide and hydrogen at the cathode. EOW is known to have antimicrobial effects against various microorganisms, including viruses, bacteria, spores and fungi. Its antimicrobial activity is generally attributed to its hypochloric acid content - a product of chlorine gas dissolved in water. Due to its biocompatibility, known uses of EOW include ocular disinfection, nasal irrigation and chronic cutaneous wound care. In the dental setting, it may be used as a mouthwash, disinfectant, irrigant, mouthwash or dental gel. The aim of this study is to investigate the effect of a mouthwash containing neutral electrolyzed water on plaque accumulation (evaluated using a disclosing agent and an intraoral scanner), gingival inflammation, MMP-8 activity and the oral microbiome. In this double-blind, cross-over, 4-day experimental gingivitis model, each subject will participate in all three arms of the study. Each arm will last 4 days, during which the subjects will be asked to refrain from toothbrushing and the use of interdental cleaning devices. Instead, they will be instructed to rinse their oral cavities twice daily with either EOW, placebo or a positive control (chlorhexidine), according to a randomisation chart (each subject will receive a different mouthwash type in every arm of the study). The outcomes will be assessed at baseline and after 4 days. A washout period of at least 7 days will be implemented between each study arm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for phase_2

Timeline
Completed

Started Jan 2023

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 5, 2023

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

January 23, 2023

Completed
9 days until next milestone

First Posted

Study publicly available on registry

February 1, 2023

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 21, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2023

Completed
Last Updated

July 13, 2023

Status Verified

January 1, 2023

Enrollment Period

2 months

First QC Date

January 23, 2023

Last Update Submit

July 12, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • 3D plaque score

    Differences in plaque scores evaluated by optical scanning

    baseline, 4 days

  • Plaque index

    Differences on plaque score evaluated using the Turesky Modification of the Quigley-Hein Plaque Index

    baseline, 4 days

Secondary Outcomes (3)

  • Modified Gingival Index

    baseline, 4 days

  • Microbiologic profile of gingival crevicular fluid

    baseline, 4 days

  • MMP-8 in gingival crevicular fluid

    baseline, 4 days

Study Arms (3)

1

OTHER

Based on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).

Other: Neutral electrolyzed waterDrug: PlaceboDrug: Chlorhexidine digluconate

2

OTHER

Based on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).

Other: Neutral electrolyzed waterDrug: PlaceboDrug: Chlorhexidine digluconate

3

OTHER

Based on a randomisation table, each participant will use either a mouthwash containing neutral electrolyzed water, placebo, or chlorhexidine digluconate twice a day instead of tooth brushing and flossing for 4 days. Each subject will receive each mouthwash type only once during the study period (he/she will receive a different mouthwash type in every arm of the study based on a randomisation table).

Other: Neutral electrolyzed waterDrug: PlaceboDrug: Chlorhexidine digluconate

Interventions

Use of mouthwash containing neutral electrolyzed water twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.

123

Use of mouthwash containing placebo twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.

123

Use of mouthwash containing chlorhexidine digluconate twice daily for 4 consecutive days instead of tooth brushing and usage of interdental cleaning devices.

123

Eligibility Criteria

Age20 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age 20 - 30 years,
  • non-smoker,
  • systemically healthy,
  • without regular systemic medication,
  • presence of at least 6 teeth in each jaw quadrant,
  • plaque index \< 10 % at baseline visit,
  • absence of periodontal pockets measuring \> 4 mm.

You may not qualify if:

  • known allergy or suspected hypersensitivity to chlorhexidine digluconate,
  • gingivitis,
  • regularly use of mouthwash as part of oral hygiene routine,
  • antibiotic treatment in the last 6 months or during the observation period,
  • pregnancy or lactation,
  • fixed or removable prosthetic devices, dental implants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Ljubljana

Ljubljana, 1000, Slovenia

Location

Related Publications (1)

  • Povsic K, Munjakovic H, Zayed N, Teughels W, Seme K, Fidler A, Gaspersic R. Electrolyzed saline as an alternative to chlorhexidine: Antimicrobial and biofilm volume outcomes in a 4-day non-brushing randomized controlled clinical trial. J Periodontol. 2026 Feb 2. doi: 10.1002/jper.70070. Online ahead of print.

MeSH Terms

Conditions

Gingivitis

Interventions

chlorhexidine gluconate

Condition Hierarchy (Ancestors)

InfectionsGingival DiseasesPeriodontal DiseasesMouth DiseasesStomatognathic Diseases

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 23, 2023

First Posted

February 1, 2023

Study Start

January 5, 2023

Primary Completion

February 21, 2023

Study Completion

June 21, 2023

Last Updated

July 13, 2023

Record last verified: 2023-01

Locations